Showing results (21-30 of 61) with videos related to
Sort By:
Pageof 7
The Prostate|February 28, 2008
Increased spermine oxidase expression in human prostate cancer and prostatic intraepithelial neoplasia tissuesAndrew C Goodwin, Sana Jadallah, Antoun Toubaji, et al.Cancer Research|March 18, 2004
Hypermethylation of CpG islands in primary and metastatic human prostate cancerSrinivasan Yegnasubramanian, Jeanne Kowalski, Mark L Gonzalgo, et al.Cancer Biology & Therapy|April 23, 2005
Immortalizing the complexity of cancer metastasis: genetic features of lethal metastatic pancreatic cancer obtained from rapid autopsyErlinda E Embuscado, Daniel Laheru, Francesca Ricci, et al.Cancer Research|August 5, 2021
Subclone Eradication Analysis Identifies Targets for Enhanced Cancer Therapy and Reveals L1 Retrotransposition as a Dynamic Source of Cancer HeterogeneityKirsi Ketola, Heidi Kaljunen, Sinja Taavitsainen, et al.Journal of Laboratory Automation|February 24, 2012
High-content screening data management for drug discovery in a small- to medium-size laboratory: results of a collaborative pilot study focused on user expectations as indicators of effectivenessCynthia A Berlinicke, Christopher F Ackermann, Steve H Chen, et al.Cold Spring Harbor Molecular Case Studies|May 6, 2016
Integrated clinical, whole-genome, and transcriptome analysis of multisampled lethal metastatic prostate cancerG Steven Bova, Heini M L Kallio, Matti Annala, et al.Plos One|March 4, 2016
Microseminoprotein-Beta Expression in Different Stages of Prostate CancerLiisa Sjöblom, Outi Saramäki, Matti Annala, et al.Molecular Biotechnology|February 9, 2005
Optimal molecular profiling of tissue and tissue components: defining the best processing and microdissection methods for biomedical applicationsG Steven Bova, Isam A Eltoum, John A Kiernan, et al.British Journal of Cancer|July 11, 2018
Constitutively active androgen receptor splice variants AR-V3, AR-V7 and AR-V9 are co-expressed in castration-resistant prostate cancer metastasesHeini M L Kallio, Reija Hieta, Leena Latonen, et al.Cancer Research|January 2, 2009
Ligand-independent androgen receptor variants derived from splicing of cryptic exons signify hormone-refractory prostate cancerRong Hu, Thomas A Dunn, Shuanzeng Wei, et al.Pageof 7